logo-loader
viewTekcapital PLC

Tekcapital soars as Belluscura files patent for oxygen system to treat respiratory illnesses brought on by coronavirus

The patent application will cover novel modular portable oxygen enrichment ventilation systems for patients suffering from chronic obstructive pulmonary diseases and acute respiratory distress syndrome

Tekcapital PLC - Tekcapital soars as Belluscura files patent for oxygen system to treat respiratory illnesses brought on by coronavirus

Tekcapital PLC (LON:TEK) shares soared on Monday as its portfolio firm Belluscura filed a patent for a portable oxygen enrichment system to treat patients suffering from respiratory illnesses brought on by infections such as coronavirus.

The IP investment firm said the patent application, which was filed alongside Belluscura’s exclusive research partner Separation Design Group, will cover novel modular portable oxygen enrichment ventilation systems for patients suffering from chronic obstructive pulmonary diseases (COPD) and acute respiratory distress syndrome (ARDS).

READ: Tekcapital portfolio company, Salarius expands North American sales penetration for SaltMe! full flavour-low sodium snack

"We are very excited about our next generation oxygen technologies.  With the launch this year of our first product, the X-PLOR portable oxygen concentrator, into the respiratory treatment field where over 250mln people suffer from [COPD], the third leading cause of death, it is critical that we continue to innovate into the ever-expanding oxygen therapy market", said Belluscura chief executive Bob Rauker.

Clifford Gross, Tekcapital CEO, said: "We are very pleased to see the additional progress of Belluscura as it continues to develop intellectual property in the oxygen therapy space that can potentially help patients with COPD and acute respiratory distress syndrome brought on by viruses such as [coronavirus].”

News of the filing sent the shares surging 34.2% to 5.5p in early trading.

Quick facts: Tekcapital PLC

Price: 5.775 GBX

LSE:TEK
Market: LSE
Market Cap: £4.55 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tekcapital PLC named herein, including the promotion by the Company of Tekcapital PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: Subdued start for FTSE 100; Centrica cuts dividend

Headlines from the Proactive UK newsroom. A subdued start to the FTSE 100 this morning as the impact of the coronavirus outbreak become even more keenly felt in the UK. British Gas owner Centrica has cut its dividend and unveiled £400mln in spending cuts to offset the impact of the...

1 day, 10 hours ago

2 min read